Collagenase clostridum histolyticum is not a substrate of CYP450 enzymes. Risk for gastrointestinal adverse events in the form of nausea motivates vigilance against insufficient intake of food, especially of carbohydrate.

It is indicated for the treatment of Dupuytrens contracture. Common side effects that can be potentially porphyrinogenic through reduction in carbohydrate intake and that also can be confused with an acute porphyria attack are is nausea. Other common side effects are pain in the extremities, arthralgia and myalgia. Less common side effects are diarrhoea, vomiting and abdominal pain.

Collagenase clostridum histolyticum is not a substrate of CYP450 enzymes (SPC).